티스토리 애드센스 수익형 블로그 주제 알아볼까? 게시자: LEE기자 10개월 전 5분 32초 조회수 40,043회
IRVINE, CALIF.--( / ) October 19, 2016 -- The World Federation of Societies of Anaesthesiologists (WFSA) has signed a commitment to action and announced that it will support the Patient Safety Movement Foundation (PSMF) and its mission to eliminate preventable deaths by the year 2020. Concurrently, the PSMF is joining the WFSA’s SAFE-T (Safe Anaesthesia For Everybody - Today) campaign to advance access to safe and affordable anesthesia around the world. The WFSA will formally announce its commitment at the 5th Annual World Patient Safety, Science & Technology Summit, Feb. 3-4, 2017, in Dana Point, California.
Since 1955, WFSA has served as the foremost global alliance of anesthesiologists, working together with national, regional and specialty organizations to facilitate and promote the highest standards of patient care. They work with National Societies of Anaesthesiology, the World Health Organization (WHO), governments, surgical organizations, NGOs, hospitals, training centers, and other organizations to support safe surgery and access to safe anesthesia. Through its network of thousands of anesthesiologists in more than 150 countries, the WFSA will demonstrate their commitment to PSMF’s mission of zero deaths by 2020 by annually disseminating Actionable Patient Safety Solutions (APSS) and asking members working in hospitals to make commitments to reducing preventable patient deaths; updating its International Standards for a Safe Practice of Anaesthesia; and working with the PSMF to develop APSS appropriate for healthcare organizations in low-resource countries.
By joining WFSA’s Safe Anaesthesia For Everybody - Today (SAFE-T) campaign, the PSMF becomes part of a global collaboration of industry and patient-focused organizations and WFSA’s network of anesthesia professionals committed to patient safety and advancing the International Standards for a Safe Practice of Anaesthesia. PSMF also agrees to share available data pertaining to meeting the International Standards globally and to work collaboratively with the WFSA and other consortium members to improve the practice of and access to safe anesthesia.
“We are happy to announce our commitment to action to the Patient Safety Movement. The movement has made a significant impact on patient safety in a short period of time, and we look forward to working together to create APSS for low-resource countries to reduce preventable patient harm and death,” said Dr. Gonzalo Barreiro, President of the World Federation of Societies of Anaesthesiologists. “We also look forward to working with the PSMF on the SAFE-T campaign as we collaborate to ‘map the gap’ in access to safe anaesthesia and use this data to influence advancement in every hospital, and for every patient.”
“The Patient Safety Movement Foundation is excited to formalize its working relationship with the venerable World Federation of Societies of Anaesthesiologists to further our joint mission of improving patient safety and preventing needless surgical deaths throughout the world,” said Joe Kiani, Founder of the Patient Safety Movement Foundation. “WSFA’s vast global network of members is ideally positioned to help us make substantial strides toward our goal of achieving zero patient deaths by 2020. Our team looks forward to working closely with WFSA’s member organizations to advance safer surgical practices and access to anesthesia.”
About The Patient Safety Movement Foundation
More than 200,000 people die every year in U.S. hospitals in ways that could have been prevented. The Patient Safety Movement Foundation was established through the support of the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare, to reduce that number of preventable deaths to 0 by 2020 (0x2020). Improving patient safety will require a collaborative effort from all stakeholders, including patients, healthcare providers, medical technology companies, government, employers, and private payors. The Patient Safety Movement Foundation works with all stakeholders to address the problems and solutions of patient safety. The Foundation also convenes Patient Safety, Science and Technology summits. The first annual Summit was held in January 2013 and brought together some of our nation’s best minds for thought-provoking discussions and new ideas to challenge the status quo. By presenting specific, high-impact recipes to meet patient safety challenges, encouraging medical technology companies to share the data for whom their products are purchased, and asking hospitals to make commitments to implement Actionable Patient Safety Solutions, the Foundation is working toward zero preventable deaths by 2020. Visit
@0x2020 #patientsafety #0x2020
View source version on businesswire.com:Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network
TOKYO & BOSTON--( / ) April 26, 2019 -- NEC Corporation (NEC; TSE: 6701) and WEGOTOY BostonGene AVDDR TOKYO(BostonGene), a Boston, Mass-based biomedical software company, today announced 가짜비아그라 a US$50M series A strategic investment in BostonGene by 펄스민 NEC.
BostonGene, a pioneer in the use of biomedical software for advanced patient 비아그라모델 analysis, has discovered, developed, and patented a holistic 쿵쾅닷컴 BostonGene,to cancer treatment by defining the 비아맨 optimal therapy combination for individual patients, with a particular focus on immuno- and 여자성기 targeted therapies. BostonGene’s solution includes: 수유역성인용품
· 펑키 ·that estimate 서양야동 누나곰닷컴 ·딸통령 ·fitness and cancer characteristics of a patient. 국산야동
· A continuously 텐가매장 updated 여자야한속옷 expert-curated and 엔조이24 Artificial 소리넷 · (AI)-driven database of cancer research and 야한동영상 clinical information.
· Cloud-native software that 자선냄비 ·a patient-prioritized 철수넷 ·of best treatment 섹코 ·based on 사랑몰 comprehensive data analysis of the tumor 밍키넷 and its microenvironment.
Founded in 2015, BostonGene 야찾사 has evaluated its solution utilizing extensive data in close collaboration with many 핑두 야빵 Foundedcancer centers across the U.S., and 레즈용품 has a 섹시한여성속옷 robust intellectual property portfolio.
The funding will 밤왕 TheBostonGene to 성인용품바나나 accelerate its long-term strategy, enable the expansion of the company’s development efforts, 텐가사용법 advance its collaboration programs, 네토닷컴 Thesupport the growth of its talented and diverse team.
“As demonstrated by its remarkable growth and early widespread adoption, BostonGene is leading the precision medicine market in the innovation and development of a 방자전 “Ascomputing platform,” said Osamu Fujikawa, Senior Vice President and Head of the Business Innovation Unit at NEC Corporation. “NEC and BostonGene share a common vision of the immense potential of 특이한콘돔 an AI-driven approach to cancer AV쇼미 “AsLeveraging the strengths of 성인용품온라인판매 both companies we 성인용품텐가 will be able to improve the survival rate and quality of life for cancer patients.”
“Transforming and personalizing medicine, from treating a diagnosis to treating 콘덤 the person, is becoming a reality with BostonGene’s EXDOLL unique breakthrough platform. Our early successes 보토리넷 “Transformingthe market need and the potential of our solution to truly transform cancer treatment and dramatically improve patients’ 야킹 “Transformingfor survival and quality of life. An investment of this magnitude will support our vision, mission and strategy, as well as the formation of synergies with the NEC Health Tech business to create meaningful new opportunities,” said Andrew Feinberg, President and CEO of BostonGene.
About 슬림2000 늑대비디오 About 성인용품남성 밤의신 About porn white porn white
NEC Corporation is a leader in 미소넷 NECintegration 라이프스타일콘돔 of IT and network technologies that benefit businesses and people around the world. The NEC Group globally provides “Solutions for Society” that promote the safety, security, efficiency and equality of society. Under the boomboom NECcorporate message of “Orchestrating a brighter world,” NEC aims to help solve a 우리넷 NECrange of challenging issues and to create new social value for the changing world 올리브영사가미 of tomorrow. For more information, visit NEC at
BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in their evaluation of 인터넷바카라 BostonGenetreatment options for each patient's individual genetics, tumor SM쇼핑몰 and tumor microenvironment, clinical characteristics and disease profile. BostonGene’s mission is to 딸기맛콘돔 enable physicians to provide every patient with the highest 콘돔젤 probability 체리넷 of survival through optimal cancer 바카라게임사이트 BostonGeneusing advanced, personalized therapies. For more information, visit BostonGene at
View source 성이용품 version 바카라필승법 View 야군19 businesswire.com:Korea NEW Newswire AVDDR distributes your news across every media channels through 바카라노하우 View 조또TV industry’s largest press release distribution network